Park Ha Biological Technology Co., Ltd. (BYAH) - Total Liabilities
Based on the latest financial reports, Park Ha Biological Technology Co., Ltd. (BYAH) has total liabilities worth $1.58 Million USD as of April 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Park Ha Biological Technology Co., Ltd. annual equity growth to track the company's year-over-year net asset growth rate.
Park Ha Biological Technology Co., Ltd. - Total Liabilities Trend (2021–2024)
This chart illustrates how Park Ha Biological Technology Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Park Ha Biological Technology Co., Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Park Ha Biological Technology Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Park Ha Biological Technology Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Medicon Hellas S.A.
AT:MEDIC
|
Greece | €14.85 Million |
|
Chinyang Poly
KO:010640
|
Korea | ₩41.97 Billion |
|
Cannabist Company Holdings Inc
NEO:CBST
|
Canada | CA$689.46 Million |
|
AAA Technologies Limited
NSE:AAATECH
|
India | Rs34.38 Million |
|
Intersport Polska S.A.
WAR:IPO
|
Poland | zł210.92 Million |
|
Sri Adhikari Brothers Television Network Limited
NSE:SABTNL
|
India | Rs171.45 Million |
|
Multibax Public Company Limited
BK:MBAX
|
Thailand | ฿956.13 Million |
|
e-future.Co.Ltd
KQ:134060
|
Korea | ₩4.56 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Park Ha Biological Technology Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Park Ha Biological Technology Co., Ltd. (BYAH) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Park Ha Biological Technology Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Park Ha Biological Technology Co., Ltd. (2021–2024)
The table below shows the annual total liabilities of Park Ha Biological Technology Co., Ltd. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-10-31 | $1.58 Million | +25.93% |
| 2023-10-31 | $1.25 Million | -47.12% |
| 2022-10-31 | $2.37 Million | +102.02% |
| 2021-10-31 | $1.17 Million | -- |
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more